Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Aggrastat
Known as:
Merck Frosst brand of tirofiban hydrochloride monohydrate
, Agrastat
, Cahill May Roberts brand of tirofiban hydrochloride monohydrate
Expand
National Institutes of Health
Create Alert
Related topics
Related topics
3 relations
15 ML tirofiban 0.25 MG/ML Injection [Aggrastat]
Broader (2)
TIROFIBAN HYDROCHLORIDE
tirofiban
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Radiolabeled tirofiban – a potential radiopharmaceutical for detection of deep venous thrombosis
Marija Darkovska-Serafimovska
,
E. Janevik-Ivanovska
,
+4 authors
N. Ugrešić
Drug design, development and therapy
2016
Corpus ID: 18846178
Aim The aim of this study was to investigate the possibility of using 99mtechnetium (99mTc)-labeled tirofiban (a reversible…
Expand
2016
2016
Effects of intracoronary tirofiban administration on diabetes mellitus complicated by acute myocardial infarction in female patients undergoing emergency percutaneous coronary intervention
Qi Chen
,
Y. Liu
,
+5 authors
Zhi-fang Zhang
2016
Corpus ID: 160030194
This study aims to investigate the short-term efficacy and safety of intracoronary tirofiban administration during emergency…
Expand
2015
2015
Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
M. Akpek
,
Omer Sahin
,
+7 authors
M. Kaya
Angiology
2015
Corpus ID: 39673754
We evaluated the acute effect of intracoronary administration of tirofiban on no-reflow phenomenon in patients with ST-segment…
Expand
2013
2013
Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous…
Tian Qi Zhu
,
Q. Zhang
,
+8 authors
W. Shen
International journal of cardiology
2013
Corpus ID: 26797442
BACKGROUND We investigated whether an additional intracoronary tirofiban bolus administration following upstream intravenous…
Expand
2011
2011
The Effect of Intracoronary Tirofiban Treatment on Acute Myocardial Infarction with ST Segment Elevation
Wu Gao-jun
2011
Corpus ID: 75813445
Objective To observe the efficacy and the safety with intracoronary use of tirofiban therapy in acute myocardium infarction…
Expand
2010
2010
Tirofiban 'bridging' therapy for patients with drug-eluting stents undergoing non-cardiac surgery.
S. Bolsin
,
M. Conroy
,
C. Osborne
British journal of anaesthesia
2010
Corpus ID: 206351256
Editor—We read with interest the report of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of…
Expand
2005
2005
Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty
T. Bilsel
,
Tamer Akbulut
,
+6 authors
F. Çiloğlu
Heart and Vessels
2005
Corpus ID: 7935692
Glycoprotein IIb/IIIa inhibitor therapy during primary percutaneous coronary intervention (PCI) decreases the incidence of major…
Expand
2003
2003
Use of Abciximab and Tirofiban in Patients with Peripheral Arterial Occlusive Disease and Arterial Thrombosis
J. Schweizer
,
W. Kirch
,
R. Koch
,
A. Mueller
,
G. Hellner
,
L. Forkmann
Angiology
2003
Corpus ID: 26039613
Acute peripheral arterial occlusive disease is an important factor affecting the mobility and mortality rate of elderly patients…
Expand
2003
2003
Effects of GP IIb/IIIa Receptor Inhibitor Tirofiban (Aggrastat) in Ex Vivo Canine Arteriovenous Shunt Model of Stent Thrombosis
V. Rukshin
,
B. Azarbal
,
+4 authors
Sanjay Kaul
Journal of cardiovascular pharmacology
2003
Corpus ID: 35214341
The authors investigated the effects of the platelet glycoprotein IIb/IIIa platelet inhibitor, tirofiban, on stent thrombosis in…
Expand
Review
2001
Review
2001
[GPIIb-IIIa inhibitors].
P. Nurden
Transfusion clinique et biologique : journal de…
2001
Corpus ID: 31431866
Therapy involving the use of anti-GPIIb-IIIa inhibitors has progressively evolved in recent years for patients undergoing…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE